NeuroMetrix shareholders to receive cash and Contingent Value Rights WOBURN, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) — NeuroMetrix, Inc. (“NeuroMetrix” or the “Company”) (Nasdaq: NURO) today announced it has entered into a definitive merger agreement whereby electroCore, Inc. (“electroCore”) (Nasdaq: ECOR), a commercial stage bioelectronic medicine and wellness company, will acquire NeuroMetrix. The transaction has been unanimously approved by the Boards of Directors of both companies and is expected to close late in the first quarter of 2025. Under the terms of the merger agreement, a subsidiary of electroCore will merge with NeuroMetrix and NeuroMetrix will become a wholly owned subsidiary of electroCore. The shareholders of NeuroMetrix will be entitled to receive the equivalent of the balance of NeuroMetrix’s net cash at the closing...

The Quell® platform will strengthen our position as a significant player in the bioelectronic health and wellness sector Company to discuss acquisition and host investor Q&A in a webcast today at 4:30 p.m. EST ROCKAWAY, N.J., Dec. 17, 2024 (GLOBE NEWSWIRE) — electroCore, Inc. (“ECOR,” “electroCore,” or the “Company”) (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today it has entered into a definitive agreement to acquire NeuroMetrix, Inc. (“NeuroMetrix” or “NURO”) (Nasdaq: NURO), including its Quell platform, positioning itself as a diversified, commercial-scale player in non-invasive health and wellness treatments. NURO is a commercial stage healthcare company that develops and commercializes neurotechnology devices to address unmet needs in the chronic pain and diabetes markets....

TORONTO, Dec. 17, 2024 (GLOBE NEWSWIRE) — Aecon Group Inc. (TSX: ARE) (“Aecon”) announced today the closing of the previously disclosed acquisition of United Engineers & Constructors (“United”). “We are excited to welcome the United team to Aecon and we look forward to harnessing our enhanced nuclear and conventional power generation capabilities and client relationships to drive continued growth in the U.S. and priority markets,” said Jean-Louis Servranckx, President and Chief Executive Officer, Aecon Group Inc.   “We are pleased to have United’s experienced operational teams and management join Aecon,” said Aaron Johnson, Senior Vice President, Nuclear, Aecon Group Inc. “Adding United’s strong technical and engineering experience complements our business, augments our collaborative partnership in Canada and expands our comprehensive...

VANCOUVER, British Columbia, Dec. 17, 2024 (GLOBE NEWSWIRE) — Dominion Lending Centres Inc. (TSX: DLCG) (“DLCG” or the “Corporation”) is pleased to announce it has completed the acquisition (the “Acquisition”) of all of the issued and outstanding non-voting Series 1 Class B preferred shares of the Corporation (the “Series 1 Preferred Shares”) from one or more companies controlled by Gary Mauris, one or more companies controlled by Chris Kayat, and from certain other holders of Series 1 Preferred Shares in exchange for, in aggregate, 30,500,000 Class A common shares (“Common Shares”) (having a market price of $122,000,000 based on a 20-day volume weighted average trading price of $4.00 per Common Share at the time of announcement of the Acquisition) and a cash payment of...

Trucker Tools joins DAT Freight & Analytics to further strengthen their combined mission to put confidence back in freight CHICAGO, Dec. 17, 2024 (GLOBE NEWSWIRE) — DAT Freight & Analytics, a leader in freight, acquired Trucker Tools, a strategic move designed to combine Trucker Tools’ innovative approach to load tracking and carrier sourcing with DAT’s experience providing industry-leading freight solutions. Brokers will continue to get best-in-class load visibility and capacity tools for every load they manage, but with nearly 50 additional years of expertise and greater resources for an enhanced suite of broker tools. Carriers can expect the same great lifestyle features they’ve come to love – weigh scales, fuel optimizers, and more. With this partnership, we’re adding one of the largest networks of loads,...

COLUMBUS, Ohio, Dec. 17, 2024 (GLOBE NEWSWIRE) — Northwest Bancshares, Inc. (“Northwest”) (NASDAQ: NWBI) the bank holding company for Northwest Bank, and Penns Woods Bancorp, Inc. (“Penns Woods”) (NASDAQ: PWOD), the multi-bank holding company of Jersey Shore State Bank and Luzerne Bank, jointly announced today that they have entered into a definitive Agreement and Plan of Merger (“Agreement”) whereby Northwest will acquire Penns Woods in an all-stock transaction valued at approximately $270.4 million. Combining the two organizations will significantly enhance the combined company’s presence in North Central and Northeastern Pennsylvania. Headquartered in Williamsport, Pennsylvania, Penns Woods has approximately $2.3 billion in assets, $1.7 billion in total deposits, and $1.9 billion in total loans as of September 30, 2024. The...

Technology will complement QuestionPro’s existing Asynchronous Qualitative Research Platform and ultimately power virtual focus groups and panels SAN FRANCISCO, Dec. 17, 2024 (GLOBE NEWSWIRE) — QuestionPro, a global leader in online survey and research services, has acquired SpatialChat, Europe’s trailblazer in video streaming and immersive virtual environments for meetings and collaboration. This strategic acquisition will add value to QuestionPro’s existing Qualitative Research and Customer Experience (CX) platforms while expanding SpatialChat’s footprint beyond Europe into the U.S. and global markets. SpatialChat is a leading virtual platform that empowers organizations to foster enhanced engagement, collaboration, and productivity in immersive digital environments. With AI capabilities, SpatialChat creates highly interactive,...

WALTHAM, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) — Danforth Advisors, LLC, today announced the acquisition of VPMR, LLC, a full-service, global market research firm serving life science and healthcare companies across all phases of the product lifecycle. Applying deep expertise in both traditional and technology-based research methods, VPMR provides vital insights to guide market opportunity assessment, new product development and strategic decision-making for clients. The acquisition extends Danforth’s capabilities in the area of commercial readiness, delivering key data to shape launch strategy and marketing. Allison Fuller will continue to lead VPMR in her role as President. “Given the high costs and stakes of drug development, market research is fundamental to optimizing chances of success. Whether to understand patient needs,...

WINTER PARK, Fla., Dec. 17, 2024 (GLOBE NEWSWIRE) — CTO Realty Growth, Inc. (NYSE: CTO) an owner and operator of high-quality, open-air shopping centers located in the higher growth Southeast and Southwest markets of the United States (the “Company”), today announced the addition of its second grocery anchored property in the Tampa, Florida market with the acquisition of Granada Plaza for $16.8 million, prior to closing costs and adjustments. Granada Plaza is a 74,000 square-foot shopping center, anchored by a high-performing Publix, and located in the city of Dunedin, Florida, a densely populated and growing retail market in the Tampa metro area. The property is situated on seven acres and is 95% occupied. “This acquisition adds another grocery anchored shopping center to our portfolio and further expands our presence in...

WESTPORT, Conn., Dec. 17, 2024 (GLOBE NEWSWIRE) — Portage Biotech, Inc. (“Portage” or the “Company”) (NASDAQ: PRTG), a clinical-stage immuno-oncology company with a portfolio of novel multi-targeted therapies for use as monotherapy and in combination, is pleased to announce that it has entered into a Letter of Intent (“LOI”) with Immunova, LLC, (“Immunova”) a private Connecticut-based biotechnology company. Under the terms of the LOI, Portage and Immunova have agreed to negotiate a definitive option agreement for Immunova or an affiliate to acquire the entire share capital of iOx Therapeutics, Ltd (“iOx”), a wholly owned subsidiary of Portage. iOx is focused on developing liposomal iNKT agonists, and its lead candidate, PORT-2, has demonstrated promising preliminary clinical activity. Alex Pickett, CEO of Portage Biotech, commented:...